SlideShare a Scribd company logo
Val in Crs
MAT MTH Val (Cr) MS% GR% Val (Cr) MS% GR% CORPORATE MAT MTH
76567 100.00 5.9 6636 100.00 8.1 IPM
1 1 4893 6.39 3.8 414 6.44 4.8 Abbott + Abbott HC + Novo `1 1
2 2 4168 5.44 15.4 377 5.34 15.2 Sun Pharma 2 2
3 3 3809 4.97 6.2 326 4.97 6.8 Cipla `2 3
4 4 3363 4.39 6.3 281 4.39 4.3 Zydus + Biochem 3 4
5 6 2836 3.70 -3.6 233 3.98 -4.7 Ranbaxy `3 7
6 5 2727 3.56 5.4 243 3.50 13.3 Mankind `5 9
7 8 2710 3.54 -15.6 227 4.02 -7.8 Glaxo 4 6
8 9 2673 3.49 9.9 226 3.39 8.3 Alkem + Cachet + Indchemie 5 8
9 7 2581 3.37 11.7 230 3.36 11.7 Lupin `4 5
10 11 2226 2.91 3.0 189 2.95 4.0 Pfizer 6 11
11 12 2162 2.82 15.0 183 2.65 12.9 Emcure + Zuventus `6 12
12 10 2056 2.69 11.5 198 2.55 26.7 Macleods 7 10
13 13 1926 2.52 0.3 175 2.65 7.7 Sanofi `7 13
14 14 1909 2.49 7.0 168 2.55 7.4 Intas 8 14
15 15 1877 2.45 14.7 164 2.17 23.1 Aristo `8 15
16 18 1667 2.18 15.7 131 1.89 13.6 Glenmark 9 18
17 16 1635 2.14 5.7 144 2.16 8.9 Dr. Reddys `9 16
18 17 1572 2.05 9.3 139 2.15 5.7 Micro + Bal 10 17
19 21 1407 1.84 9.1 118 1.87 3.1 USV `10 21
20 19 1394 1.82 14.0 127 1.79 15.1 Torrent 11 19
21 20 1372 1.79 20.4 124 1.59 27.8 IPCA `11 20
22 22 1222 1.60 3.0 102 1.53 8.6 Wockhardt 12 22
23 23 1133 1.48 -1.3 94 1.55 -1.4 Novartis `12 23
24 24 1056 1.38 10.5 86 1.23 13.4 Alembic 13 24
25 25 812 1.06 2.3 72 1.13 2.8 FDC `13 25
26 27 793 1.04 8.2 70 0.98 16.1 Unichem 14 27
27 26 784 1.02 7.7 70 0.95 19.6 MSD + Fulford + Organon `14 26
28 28 616 0.80 11.4 55 0.83 7.7 Cadila 15 28
29 29 592 0.77 5.3 50 0.72 13.2 Indoco Remedies 16 30
30 31 567 0.74 11.6 48 0.69 13.5 Franco `16 31
31 30 566 0.74 24.1 50 0.72 13.4 Eris `15 29
32 32 470 0.61 3.0 44 0.63 14.1 Himalaya 17 32
33 34 465 0.61 8.9 42 0.60 13.9 Merck `17 34
34 43 429 0.56 -41.4 30 0.97 -49.8 Elder 18 42
35 37 423 0.55 1.5 35 0.50 14.2 Blue Cross `19 37
36 33 405 0.53 11.0 43 0.65 6.8 JB Chemicals 19 33
37 40 395 0.52 16.7 32 0.51 0.9 Astrazeneca `18 39
38 39 383 0.50 -10.7 32 0.65 -19.7 Bharat Serums 20 40
39 36 376 0.49 -1.0 35 0.54 5.5 Raptakos, Brett `20 35
40 35 372 0.49 21.0 35 0.45 27.5 Meyer Organics 21 36
41 38 361 0.47 7.8 33 0.46 16.8 Wallace + Indi Pharma `21 38
42 45 347 0.45 11.6 28 0.39 17.0 Hetero `23 51
With Bonus Units at Full Value Witho
Rank MAT May-14 May-14 Rank
43 42 333 0.43 7.6 30 0.44 10.4 Medley 23 43
44 44 330 0.43 0.6 29 0.45 3.3 Win-Medicare 22 44
45 41 318 0.41 33.4 31 0.33 54.1 Akumentis 24 41
46 48 317 0.41 10.8 27 0.41 8.1 Janssen `22 46
47 47 311 0.41 3.3 27 0.44 2.1 Albert David `24 47
48 50 293 0.38 47.9 26 0.30 44.8 Biocon 25 49
49 46 284 0.37 33.4 28 0.31 45.0 Ajanta `25 45
50 52 277 0.36 25.2 26 0.37 14.3 Hegde & Hegde 26 50
Val (Cr) MS% GR% Val (Cr) MS% GR%
73629 100.00 5.9 6397 100.00 8.7
4794 6.51 3.5 407 6.36 5.2
4073 5.53 14.4 370 5.78 15.2
3572 4.85 9.0 307 4.80 10.3
3143 4.27 6.1 264 4.12 5.7
2743 3.73 -3.6 225 3.52 -4.7
2306 3.13 6.9 208 3.25 16.9
2675 3.63 -14.9 226 3.53 -6.2
2483 3.37 9.7 212 3.31 10.0
2524 3.43 11.6 226 3.53 12.1
2176 2.95 3.3 185 2.89 4.6
2097 2.85 15.3 178 2.78 13.5
1927 2.62 11.2 186 2.90 26.8
1890 2.57 0.0 172 2.68 7.6
1884 2.56 6.4 166 2.60 7.7
1654 2.25 11.9 143 2.23 20.5
1619 2.20 15.3 128 2.00 13.4
1602 2.18 4.9 141 2.21 8.8
1503 2.04 9.9 134 2.09 6.3
1401 1.90 9.0 118 1.84 3.4
1370 1.86 13.8 124 1.94 14.5
1305 1.77 20.0 120 1.87 29.4
1197 1.63 2.7 100 1.56 8.7
1092 1.48 -0.6 91 1.42 0.4
1023 1.39 11.0 83 1.30 14.3
790 1.07 2.2 69 1.08 3.2
776 1.05 7.5 68 1.06 16.1
774 1.05 7.6 69 1.07 18.8
594 0.81 11.2 53 0.83 7.6
551 0.75 5.6 47 0.73 13.4
546 0.74 11.0 46 0.72 13.3
563 0.76 23.9 50 0.77 13.3
468 0.64 2.6 44 0.68 13.8
454 0.62 7.5 41 0.64 12.6
413 0.56 -39.8 29 0.46 -47.7
389 0.53 3.5 32 0.50 13.5
389 0.53 10.8 41 0.64 6.1
391 0.53 15.8 31 0.49 0.5
375 0.51 -11.2 31 0.49 -19.9
371 0.50 -1.3 35 0.54 5.6
360 0.49 20.8 34 0.53 27.5
331 0.45 11.7 32 0.50 28.5
315 0.43 11.9 25 0.40 17.9
Without Bonus Units
MAT May -14 May-14
316 0.43 8.3 29 0.45 10.3
325 0.44 -0.6 28 0.44 1.7
311 0.42 35.4 31 0.48 54.7
317 0.43 10.7 27 0.43 8.1
305 0.41 3.2 27 0.42 1.9
292 0.40 47.9 26 0.41 44.7
282 0.38 33.3 27 0.43 44.9
276 0.38 25.2 26 0.40 14.3

More Related Content

What's hot

Chapter 1 form 4
Chapter 1 form 4Chapter 1 form 4
Chapter 1 form 4
Puteri Merdu
 
Bobcat S175 S185 Skid Steer Loader Parts Catalogue Manual S/N 5253 11001 & Above
Bobcat S175 S185 Skid Steer Loader Parts Catalogue Manual S/N 5253 11001 & AboveBobcat S175 S185 Skid Steer Loader Parts Catalogue Manual S/N 5253 11001 & Above
Bobcat S175 S185 Skid Steer Loader Parts Catalogue Manual S/N 5253 11001 & Above
hskekdmmm
 
CHEMISTRY FORM 4 KSSM CHAPTER 4
CHEMISTRY FORM 4 KSSM CHAPTER 4CHEMISTRY FORM 4 KSSM CHAPTER 4
CHEMISTRY FORM 4 KSSM CHAPTER 4
MISS ESTHER
 
Massey ferguson mf 440 combine parts catalogue manual
Massey ferguson mf 440 combine parts catalogue manualMassey ferguson mf 440 combine parts catalogue manual
Massey ferguson mf 440 combine parts catalogue manual
dhjfjkmmmde
 
MANUAL PARTES GIXXER
MANUAL PARTES GIXXERMANUAL PARTES GIXXER
MANUAL PARTES GIXXER
ARIEL BALBUENA
 
A53 mp
A53 mpA53 mp
A53 mp
Mario Ticona
 
kimia-periode 3 dan unsur transisi periode 4
kimia-periode 3 dan unsur transisi periode 4kimia-periode 3 dan unsur transisi periode 4
kimia-periode 3 dan unsur transisi periode 4muharomah
 
Bobcat 553 AF BF Series Skid Steer Loader Parts Catalogue Manual S/N 52811100...
Bobcat 553 AF BF Series Skid Steer Loader Parts Catalogue Manual S/N 52811100...Bobcat 553 AF BF Series Skid Steer Loader Parts Catalogue Manual S/N 52811100...
Bobcat 553 AF BF Series Skid Steer Loader Parts Catalogue Manual S/N 52811100...
hdksemmme
 
Unsur periode 3
Unsur periode 3Unsur periode 3
Unsur periode 3
Magma Rachmani
 
Unit 4 ikatan kimia
Unit 4 ikatan kimiaUnit 4 ikatan kimia
Unit 4 ikatan kimia
Muhammad Helmy Rani
 
GOLONGAN III & IV A
GOLONGAN III & IV A GOLONGAN III & IV A
GOLONGAN III & IV A
Erli fharida
 
Perkembangan sistem periodik
Perkembangan sistem periodik Perkembangan sistem periodik
Perkembangan sistem periodik
Lathifah Nur Zahra
 
Cembre Cable Crimp Lugs (Single Hole - Copper Conductors) - A Range
Cembre Cable Crimp Lugs (Single Hole - Copper Conductors) - A RangeCembre Cable Crimp Lugs (Single Hole - Copper Conductors) - A Range
Cembre Cable Crimp Lugs (Single Hole - Copper Conductors) - A Range
Thorne & Derrick International
 
Ansi b.16.5
Ansi b.16.5Ansi b.16.5
Ansi b.16.5
webjuankr25
 
Daewoo doosan solar 280 lc ⅲ crawler excavator parts catalogue manual
Daewoo doosan solar 280 lc ⅲ crawler excavator parts catalogue manualDaewoo doosan solar 280 lc ⅲ crawler excavator parts catalogue manual
Daewoo doosan solar 280 lc ⅲ crawler excavator parts catalogue manual
f9soeikdkdk
 
SPE Process Safety Workshop PPT Slides
SPE Process Safety Workshop PPT SlidesSPE Process Safety Workshop PPT Slides
SPE Process Safety Workshop PPT Slides
idell bryan
 
Unsur kimia periode 3
Unsur kimia periode 3Unsur kimia periode 3
Unsur kimia periode 3
Sodik Sumadi
 
Group 18 elements
Group 18 elements Group 18 elements
Group 18 elements
Aratatran Patra
 
Pipe schedule 1
Pipe schedule 1Pipe schedule 1
Pipe schedule 1
Engr. Anwarul Zahid
 

What's hot (20)

Chapter 1 form 4
Chapter 1 form 4Chapter 1 form 4
Chapter 1 form 4
 
Bobcat S175 S185 Skid Steer Loader Parts Catalogue Manual S/N 5253 11001 & Above
Bobcat S175 S185 Skid Steer Loader Parts Catalogue Manual S/N 5253 11001 & AboveBobcat S175 S185 Skid Steer Loader Parts Catalogue Manual S/N 5253 11001 & Above
Bobcat S175 S185 Skid Steer Loader Parts Catalogue Manual S/N 5253 11001 & Above
 
CHEMISTRY FORM 4 KSSM CHAPTER 4
CHEMISTRY FORM 4 KSSM CHAPTER 4CHEMISTRY FORM 4 KSSM CHAPTER 4
CHEMISTRY FORM 4 KSSM CHAPTER 4
 
Massey ferguson mf 440 combine parts catalogue manual
Massey ferguson mf 440 combine parts catalogue manualMassey ferguson mf 440 combine parts catalogue manual
Massey ferguson mf 440 combine parts catalogue manual
 
MANUAL PARTES GIXXER
MANUAL PARTES GIXXERMANUAL PARTES GIXXER
MANUAL PARTES GIXXER
 
A53 mp
A53 mpA53 mp
A53 mp
 
kimia-periode 3 dan unsur transisi periode 4
kimia-periode 3 dan unsur transisi periode 4kimia-periode 3 dan unsur transisi periode 4
kimia-periode 3 dan unsur transisi periode 4
 
Bobcat 553 AF BF Series Skid Steer Loader Parts Catalogue Manual S/N 52811100...
Bobcat 553 AF BF Series Skid Steer Loader Parts Catalogue Manual S/N 52811100...Bobcat 553 AF BF Series Skid Steer Loader Parts Catalogue Manual S/N 52811100...
Bobcat 553 AF BF Series Skid Steer Loader Parts Catalogue Manual S/N 52811100...
 
Unsur periode 3
Unsur periode 3Unsur periode 3
Unsur periode 3
 
Unit 4 ikatan kimia
Unit 4 ikatan kimiaUnit 4 ikatan kimia
Unit 4 ikatan kimia
 
GOLONGAN III & IV A
GOLONGAN III & IV A GOLONGAN III & IV A
GOLONGAN III & IV A
 
Perkembangan sistem periodik
Perkembangan sistem periodik Perkembangan sistem periodik
Perkembangan sistem periodik
 
Cembre Cable Crimp Lugs (Single Hole - Copper Conductors) - A Range
Cembre Cable Crimp Lugs (Single Hole - Copper Conductors) - A RangeCembre Cable Crimp Lugs (Single Hole - Copper Conductors) - A Range
Cembre Cable Crimp Lugs (Single Hole - Copper Conductors) - A Range
 
Ansi b.16.5
Ansi b.16.5Ansi b.16.5
Ansi b.16.5
 
Daewoo doosan solar 280 lc ⅲ crawler excavator parts catalogue manual
Daewoo doosan solar 280 lc ⅲ crawler excavator parts catalogue manualDaewoo doosan solar 280 lc ⅲ crawler excavator parts catalogue manual
Daewoo doosan solar 280 lc ⅲ crawler excavator parts catalogue manual
 
SPE Process Safety Workshop PPT Slides
SPE Process Safety Workshop PPT SlidesSPE Process Safety Workshop PPT Slides
SPE Process Safety Workshop PPT Slides
 
Kimia unsur
Kimia unsurKimia unsur
Kimia unsur
 
Unsur kimia periode 3
Unsur kimia periode 3Unsur kimia periode 3
Unsur kimia periode 3
 
Group 18 elements
Group 18 elements Group 18 elements
Group 18 elements
 
Pipe schedule 1
Pipe schedule 1Pipe schedule 1
Pipe schedule 1
 

More from Anup Soans

An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
Anup Soans
 
Key Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way ForwardKey Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way Forward
Anup Soans
 
Trends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and SpendingTrends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and Spending
Anup Soans
 
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27thMedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
Anup Soans
 
Key Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAMKey Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAM
Anup Soans
 
MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021
Anup Soans
 
How can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand PatientsHow can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand Patients
Anup Soans
 
Why Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop TalentWhy Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop Talent
Anup Soans
 
Digital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification ProgramDigital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification Program
Anup Soans
 
Digital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification ProgramDigital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification Program
Anup Soans
 
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family AffairsCOVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
Anup Soans
 
Architecture To Develop Pharma Business Leaders For Today and Tomorrow
Architecture To Develop Pharma Business Leaders  For Today and Tomorrow  Architecture To Develop Pharma Business Leaders  For Today and Tomorrow
Architecture To Develop Pharma Business Leaders For Today and Tomorrow
Anup Soans
 
What is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research ProjectWhat is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research Project
Anup Soans
 
Digital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification ProgramDigital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification Program
Anup Soans
 
Telemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian DoctorsTelemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian Doctors
Anup Soans
 
The Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit GhoshalThe Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit Ghoshal
Anup Soans
 
Indian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View PollIndian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View Poll
Anup Soans
 
Healthcare's Future will be Patient Experience
Healthcare's Future will be Patient ExperienceHealthcare's Future will be Patient Experience
Healthcare's Future will be Patient Experience
Anup Soans
 
Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan
Anup Soans
 
MedicinMan December 2018 Issue
MedicinMan December 2018 IssueMedicinMan December 2018 Issue
MedicinMan December 2018 Issue
Anup Soans
 

More from Anup Soans (20)

An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
 
Key Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way ForwardKey Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way Forward
 
Trends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and SpendingTrends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and Spending
 
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27thMedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
 
Key Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAMKey Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAM
 
MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021
 
How can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand PatientsHow can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand Patients
 
Why Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop TalentWhy Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop Talent
 
Digital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification ProgramDigital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification Program
 
Digital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification ProgramDigital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification Program
 
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family AffairsCOVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
 
Architecture To Develop Pharma Business Leaders For Today and Tomorrow
Architecture To Develop Pharma Business Leaders  For Today and Tomorrow  Architecture To Develop Pharma Business Leaders  For Today and Tomorrow
Architecture To Develop Pharma Business Leaders For Today and Tomorrow
 
What is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research ProjectWhat is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research Project
 
Digital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification ProgramDigital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification Program
 
Telemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian DoctorsTelemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian Doctors
 
The Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit GhoshalThe Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit Ghoshal
 
Indian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View PollIndian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View Poll
 
Healthcare's Future will be Patient Experience
Healthcare's Future will be Patient ExperienceHealthcare's Future will be Patient Experience
Healthcare's Future will be Patient Experience
 
Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan
 
MedicinMan December 2018 Issue
MedicinMan December 2018 IssueMedicinMan December 2018 Issue
MedicinMan December 2018 Issue
 

Indian Pharma Top 50 Companies - May 2014

  • 1. Val in Crs MAT MTH Val (Cr) MS% GR% Val (Cr) MS% GR% CORPORATE MAT MTH 76567 100.00 5.9 6636 100.00 8.1 IPM 1 1 4893 6.39 3.8 414 6.44 4.8 Abbott + Abbott HC + Novo `1 1 2 2 4168 5.44 15.4 377 5.34 15.2 Sun Pharma 2 2 3 3 3809 4.97 6.2 326 4.97 6.8 Cipla `2 3 4 4 3363 4.39 6.3 281 4.39 4.3 Zydus + Biochem 3 4 5 6 2836 3.70 -3.6 233 3.98 -4.7 Ranbaxy `3 7 6 5 2727 3.56 5.4 243 3.50 13.3 Mankind `5 9 7 8 2710 3.54 -15.6 227 4.02 -7.8 Glaxo 4 6 8 9 2673 3.49 9.9 226 3.39 8.3 Alkem + Cachet + Indchemie 5 8 9 7 2581 3.37 11.7 230 3.36 11.7 Lupin `4 5 10 11 2226 2.91 3.0 189 2.95 4.0 Pfizer 6 11 11 12 2162 2.82 15.0 183 2.65 12.9 Emcure + Zuventus `6 12 12 10 2056 2.69 11.5 198 2.55 26.7 Macleods 7 10 13 13 1926 2.52 0.3 175 2.65 7.7 Sanofi `7 13 14 14 1909 2.49 7.0 168 2.55 7.4 Intas 8 14 15 15 1877 2.45 14.7 164 2.17 23.1 Aristo `8 15 16 18 1667 2.18 15.7 131 1.89 13.6 Glenmark 9 18 17 16 1635 2.14 5.7 144 2.16 8.9 Dr. Reddys `9 16 18 17 1572 2.05 9.3 139 2.15 5.7 Micro + Bal 10 17 19 21 1407 1.84 9.1 118 1.87 3.1 USV `10 21 20 19 1394 1.82 14.0 127 1.79 15.1 Torrent 11 19 21 20 1372 1.79 20.4 124 1.59 27.8 IPCA `11 20 22 22 1222 1.60 3.0 102 1.53 8.6 Wockhardt 12 22 23 23 1133 1.48 -1.3 94 1.55 -1.4 Novartis `12 23 24 24 1056 1.38 10.5 86 1.23 13.4 Alembic 13 24 25 25 812 1.06 2.3 72 1.13 2.8 FDC `13 25 26 27 793 1.04 8.2 70 0.98 16.1 Unichem 14 27 27 26 784 1.02 7.7 70 0.95 19.6 MSD + Fulford + Organon `14 26 28 28 616 0.80 11.4 55 0.83 7.7 Cadila 15 28 29 29 592 0.77 5.3 50 0.72 13.2 Indoco Remedies 16 30 30 31 567 0.74 11.6 48 0.69 13.5 Franco `16 31 31 30 566 0.74 24.1 50 0.72 13.4 Eris `15 29 32 32 470 0.61 3.0 44 0.63 14.1 Himalaya 17 32 33 34 465 0.61 8.9 42 0.60 13.9 Merck `17 34 34 43 429 0.56 -41.4 30 0.97 -49.8 Elder 18 42 35 37 423 0.55 1.5 35 0.50 14.2 Blue Cross `19 37 36 33 405 0.53 11.0 43 0.65 6.8 JB Chemicals 19 33 37 40 395 0.52 16.7 32 0.51 0.9 Astrazeneca `18 39 38 39 383 0.50 -10.7 32 0.65 -19.7 Bharat Serums 20 40 39 36 376 0.49 -1.0 35 0.54 5.5 Raptakos, Brett `20 35 40 35 372 0.49 21.0 35 0.45 27.5 Meyer Organics 21 36 41 38 361 0.47 7.8 33 0.46 16.8 Wallace + Indi Pharma `21 38 42 45 347 0.45 11.6 28 0.39 17.0 Hetero `23 51 With Bonus Units at Full Value Witho Rank MAT May-14 May-14 Rank
  • 2. 43 42 333 0.43 7.6 30 0.44 10.4 Medley 23 43 44 44 330 0.43 0.6 29 0.45 3.3 Win-Medicare 22 44 45 41 318 0.41 33.4 31 0.33 54.1 Akumentis 24 41 46 48 317 0.41 10.8 27 0.41 8.1 Janssen `22 46 47 47 311 0.41 3.3 27 0.44 2.1 Albert David `24 47 48 50 293 0.38 47.9 26 0.30 44.8 Biocon 25 49 49 46 284 0.37 33.4 28 0.31 45.0 Ajanta `25 45 50 52 277 0.36 25.2 26 0.37 14.3 Hegde & Hegde 26 50
  • 3. Val (Cr) MS% GR% Val (Cr) MS% GR% 73629 100.00 5.9 6397 100.00 8.7 4794 6.51 3.5 407 6.36 5.2 4073 5.53 14.4 370 5.78 15.2 3572 4.85 9.0 307 4.80 10.3 3143 4.27 6.1 264 4.12 5.7 2743 3.73 -3.6 225 3.52 -4.7 2306 3.13 6.9 208 3.25 16.9 2675 3.63 -14.9 226 3.53 -6.2 2483 3.37 9.7 212 3.31 10.0 2524 3.43 11.6 226 3.53 12.1 2176 2.95 3.3 185 2.89 4.6 2097 2.85 15.3 178 2.78 13.5 1927 2.62 11.2 186 2.90 26.8 1890 2.57 0.0 172 2.68 7.6 1884 2.56 6.4 166 2.60 7.7 1654 2.25 11.9 143 2.23 20.5 1619 2.20 15.3 128 2.00 13.4 1602 2.18 4.9 141 2.21 8.8 1503 2.04 9.9 134 2.09 6.3 1401 1.90 9.0 118 1.84 3.4 1370 1.86 13.8 124 1.94 14.5 1305 1.77 20.0 120 1.87 29.4 1197 1.63 2.7 100 1.56 8.7 1092 1.48 -0.6 91 1.42 0.4 1023 1.39 11.0 83 1.30 14.3 790 1.07 2.2 69 1.08 3.2 776 1.05 7.5 68 1.06 16.1 774 1.05 7.6 69 1.07 18.8 594 0.81 11.2 53 0.83 7.6 551 0.75 5.6 47 0.73 13.4 546 0.74 11.0 46 0.72 13.3 563 0.76 23.9 50 0.77 13.3 468 0.64 2.6 44 0.68 13.8 454 0.62 7.5 41 0.64 12.6 413 0.56 -39.8 29 0.46 -47.7 389 0.53 3.5 32 0.50 13.5 389 0.53 10.8 41 0.64 6.1 391 0.53 15.8 31 0.49 0.5 375 0.51 -11.2 31 0.49 -19.9 371 0.50 -1.3 35 0.54 5.6 360 0.49 20.8 34 0.53 27.5 331 0.45 11.7 32 0.50 28.5 315 0.43 11.9 25 0.40 17.9 Without Bonus Units MAT May -14 May-14
  • 4. 316 0.43 8.3 29 0.45 10.3 325 0.44 -0.6 28 0.44 1.7 311 0.42 35.4 31 0.48 54.7 317 0.43 10.7 27 0.43 8.1 305 0.41 3.2 27 0.42 1.9 292 0.40 47.9 26 0.41 44.7 282 0.38 33.3 27 0.43 44.9 276 0.38 25.2 26 0.40 14.3